84 related articles for article (PubMed ID: 10878450)
1. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
2. Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis.
Yao JF; Li XJ; Yan LK; He S; Zheng JB; Wang XR; Zhou PH; Zhang L; Wei GB; Sun XJ
J Biochem Mol Toxicol; 2019 Jun; 33(6):e22316. PubMed ID: 30897285
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer.
Bradley CA; Dunne PD; Bingham V; McQuaid S; Khawaja H; Craig S; James J; Moore WL; McArt DG; Lawler M; Dasgupta S; Johnston PG; Van Schaeybroeck S
Oncotarget; 2016 Nov; 7(48):78932-78945. PubMed ID: 27793046
[TBL] [Abstract][Full Text] [Related]
4. p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.
Rambau PF; Odida M; Wabinga H
Afr Health Sci; 2008 Dec; 8(4):234-8. PubMed ID: 20589130
[TBL] [Abstract][Full Text] [Related]
5. Correlation between HGF/c-Met and Notch1 signaling pathways in human gastric cancer cells.
Huang KH; Sung IC; Fang WL; Chi CW; Yeh TS; Lee HC; Yin PH; Li AF; Wu CW; Shyr YM; Yang MH
Oncol Rep; 2018 Jul; 40(1):294-302. PubMed ID: 29781036
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer.
Wielenga VJ; van der Voort R; Taher TE; Smit L; Beuling EA; van Krimpen C; Spaargaren M; Pals ST
Am J Pathol; 2000 Nov; 157(5):1563-73. PubMed ID: 11073815
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases.
Wang C; Xi W; Ji J; Cai Q; Zhao Q; Jiang J; Zhou C; Shi M; Zhang H; Zhu Z; Zhang J
Int J Med Sci; 2020; 17(13):1946-1955. PubMed ID: 32788873
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer.
Jones VT; Graves-Deal R; Cao Z; Bogatcheva G; Ramirez MA; Harmych SJ; Higginbotham JN; Sharma V; Damalanka VC; Wahoski CC; Joshi N; Irudayam MJ; Roland JT; Ayers GD; Liu Q; Coffey RJ; Janetka JW; Singh B
Cell Mol Life Sci; 2024 Jan; 81(1):28. PubMed ID: 38212428
[TBL] [Abstract][Full Text] [Related]
10. Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor.
Dong G; Lee TL; Yeh NT; Geoghegan J; Van Waes C; Chen Z
Oncogene; 2004 Aug; 23(37):6199-208. PubMed ID: 15221009
[TBL] [Abstract][Full Text] [Related]
11. Role of cMET in the development and progression of colorectal cancer.
Samamé Pérez-Vargas JC; Biondani P; Maggi C; Gariboldi M; Gloghini A; Inno A; Volpi CC; Gualeni AV; di Bartolomeo M; de Braud F; Castano A; Bossi I; Pietrantonio F
Int J Mol Sci; 2013 Sep; 14(9):18056-77. PubMed ID: 24005867
[TBL] [Abstract][Full Text] [Related]
12. Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF-PU.1-DPP4 Axis.
Wang L; Wang E; Prado Balcazar J; Wu Z; Xiang K; Wang Y; Huang Q; Negrete M; Chen KY; Li W; Fu Y; Dohlman A; Mines R; Zhang L; Kobayashi Y; Chen T; Shi G; Shen JP; Kopetz S; Tata PR; Moreno V; Gersbach C; Crawford G; Hsu D; Huang E; Bu P; Shen X
Adv Sci (Weinh); 2021 Oct; 8(19):e2004673. PubMed ID: 34378358
[TBL] [Abstract][Full Text] [Related]
13. Underexpression of mineralocorticoid receptor in colorectal carcinomas and association with VEGFR-2 overexpression.
Di Fabio F; Alvarado C; Majdan A; Gologan A; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M
J Gastrointest Surg; 2007 Nov; 11(11):1521-8. PubMed ID: 17703341
[TBL] [Abstract][Full Text] [Related]
14. Expression of Concern: HGF and c-Met Interaction Promotes Migration in Human Chondrosarcoma Cells.
PLOS ONE Editors
PLoS One; 2024; 19(1):e0297300. PubMed ID: 38206928
[No Abstract] [Full Text] [Related]
15. Expression of the hepatocyte growth factor and c-Met in colon cancer: correlation with clinicopathological features and overall survival.
Liu Y; Li Q; Zhu L
Tumori; 2012; 98(1):105-12. PubMed ID: 22495710
[TBL] [Abstract][Full Text] [Related]
16. Targeting the HGF/Met signaling pathway in cancer therapy.
Cecchi F; Rabe DC; Bottaro DP
Expert Opin Ther Targets; 2012 Jun; 16(6):553-72. PubMed ID: 22530990
[TBL] [Abstract][Full Text] [Related]
17. HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.
Liska D; Chen CT; Bachleitner-Hofmann T; Christensen JG; Weiser MR
Clin Cancer Res; 2011 Feb; 17(3):472-82. PubMed ID: 21098338
[TBL] [Abstract][Full Text] [Related]
18. The potential therapeutic and prognostic impacts of the c-MET/HGF signaling pathway in colorectal cancer.
Parizadeh SM; Jafarzadeh-Esfehani R; Fazilat-Panah D; Hassanian SM; Shahidsales S; Khazaei M; Parizadeh SMR; Ghayour-Mobarhan M; Ferns GA; Avan A
IUBMB Life; 2019 Jul; 71(7):802-811. PubMed ID: 31116909
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinases: biological functions and anticancer targeted therapy.
Zhang N; Li Y
MedComm (2020); 2023 Dec; 4(6):e446. PubMed ID: 38077251
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond.
Al Bitar S; El-Sabban M; Doughan S; Abou-Kheir W
World J Gastroenterol; 2023 Mar; 29(9):1395-1426. PubMed ID: 36998426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]